144 related articles for article (PubMed ID: 2988621)
1. The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole.
Lorentzon P; Eklundh B; Brändström A; Wallmark B
Biochim Biophys Acta; 1985 Jul; 817(1):25-32. PubMed ID: 2988621
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.
Lorentzon P; Jackson R; Wallmark B; Sachs G
Biochim Biophys Acta; 1987 Feb; 897(1):41-51. PubMed ID: 3026477
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
Im WB; Sih JC; Blakeman DP; McGrath JP
J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
[TBL] [Abstract][Full Text] [Related]
4. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
Wallmark B; Brändström A; Larsson H
Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.
Wallmark B; Sachs G; Mardh S; Fellenius E
Biochim Biophys Acta; 1983 Feb; 728(1):31-8. PubMed ID: 6299338
[TBL] [Abstract][Full Text] [Related]
6. Specific labelling of gastric H+,K+-ATPase by omeprazole.
Fryklund J; Gedda K; Wallmark B
Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of action of omeprazole.
Keeling DJ; Fallowfield C; Milliner KJ; Tingley SK; Ife RJ; Underwood AH
Biochem Pharmacol; 1985 Aug; 34(16):2967-73. PubMed ID: 2992525
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of H+,K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl)-benzimidazole-4-carboxylate (ALE-36).
Yamamoto O; Tanaka H; Ueda F; Kimura K
Scand J Gastroenterol Suppl; 1989; 162():178-81. PubMed ID: 2556788
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
10. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
Besancon M; Simon A; Sachs G; Shin JM
J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
[TBL] [Abstract][Full Text] [Related]
11. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
Morii M; Takata H; Fujisaki H; Takeguchi N
Biochem Pharmacol; 1990 Feb; 39(4):661-7. PubMed ID: 2154989
[TBL] [Abstract][Full Text] [Related]
12. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
Fryklund J; Wallmark B
J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of omeprazole.
Wallmark B
Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640
[TBL] [Abstract][Full Text] [Related]
14. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
[TBL] [Abstract][Full Text] [Related]
15. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
Im WB; Blakeman DP; Davis JP
Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
[TBL] [Abstract][Full Text] [Related]
17. Gastric H(+)-K(+)-ATPase activity is inhibited by reduction of disulfide bonds in beta-subunit.
Chow DC; Browning CM; Forte JG
Am J Physiol; 1992 Jul; 263(1 Pt 1):C39-46. PubMed ID: 1322043
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastric K+/H+-ATPase by acid-activated 2-((2-pyridylmethyl)sulphinyl)benzimidazole products.
Beil W; Hannemann H; Mädge S; Sewing KF
Eur J Pharmacol; 1987 Jan; 133(1):37-45. PubMed ID: 3030771
[TBL] [Abstract][Full Text] [Related]
19. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
Morii M; Takeguchi N
J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H(+)-K+)-ATPase.
Dantzig AH; Minor PL; Garrigus JL; Fukuda DS; Mynderse JS
Biochem Pharmacol; 1991 Oct; 42(10):2019-26. PubMed ID: 1683772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
